It may have been a blessing in disguise that our B
Post# of 148260
(Total Views: 533)
Posted On: 01/23/2022 12:27:47 PM
Re: Buddyboy20 #115779
It may have been a blessing in disguise that our Brazil trials are taking extra time to enroll, as we would not have had enough Omnicron patients n the mix several months ago. We need to show effectiveness against Omnicron to get approval, and we will do that!
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼